View in EDS PDF Full Text

TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.

Saved in:
Bibliographic Details
Title: TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.
Authors: Burris, Howard Howard.Burris@scresearch.net, Kurkjian, C., Hart, L., Pant, S., Murphy, P., Jones, S.1, Neuwirth, R.2, Patel, C.2, Zohren, F.2, Infante, J., Burris, Howard A 3rd3,4 (AUTHOR), Kurkjian, C D3,5 (AUTHOR), Murphy, P B3,4 (AUTHOR), Jones, S F3 (AUTHOR), Patel, C G6 (AUTHOR), Infante, J R3,4 (AUTHOR)
Source: Cancer Chemotherapy & Pharmacology. Aug2017, Vol. 80 Issue 2, p261-273. 13p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 124332577
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Burris%2C+Howard%22">Burris, Howard</searchLink><i> Howard.Burris@scresearch.net</i><br /><searchLink fieldCode="AR" term="%22Kurkjian%2C+C%2E%22">Kurkjian, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Hart%2C+L%2E%22">Hart, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Pant%2C+S%2E%22">Pant, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Murphy%2C+P%2E%22">Murphy, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Jones%2C+S%2E%22">Jones, S.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Neuwirth%2C+R%2E%22">Neuwirth, R.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Patel%2C+C%2E%22">Patel, C.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Zohren%2C+F%2E%22">Zohren, F.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Infante%2C+J%2E%22">Infante, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Burris%2C+Howard+A+3rd%22">Burris, Howard A 3rd</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kurkjian%2C+C+D%22">Kurkjian, C D</searchLink><relatesTo>3,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murphy%2C+P+B%22">Murphy, P B</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jones%2C+S+F%22">Jones, S F</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+C+G%22">Patel, C G</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Infante%2C+J+R%22">Infante, J R</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Chemotherapy+%26+Pharmacology%22">Cancer Chemotherapy & Pharmacology</searchLink>. Aug2017, Vol. 80 Issue 2, p261-273. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=124332577
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-017-3343-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 261
    Titles:
      – TitleFull: TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burris, Howard
      – PersonEntity:
          Name:
            NameFull: Kurkjian, C.
      – PersonEntity:
          Name:
            NameFull: Hart, L.
      – PersonEntity:
          Name:
            NameFull: Pant, S.
      – PersonEntity:
          Name:
            NameFull: Murphy, P.
      – PersonEntity:
          Name:
            NameFull: Jones, S.
      – PersonEntity:
          Name:
            NameFull: Neuwirth, R.
      – PersonEntity:
          Name:
            NameFull: Patel, C.
      – PersonEntity:
          Name:
            NameFull: Zohren, F.
      – PersonEntity:
          Name:
            NameFull: Infante, J.
      – PersonEntity:
          Name:
            NameFull: Burris, Howard A 3rd
      – PersonEntity:
          Name:
            NameFull: Kurkjian, C D
      – PersonEntity:
          Name:
            NameFull: Murphy, P B
      – PersonEntity:
          Name:
            NameFull: Jones, S F
      – PersonEntity:
          Name:
            NameFull: Patel, C G
      – PersonEntity:
          Name:
            NameFull: Infante, J R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2017
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-print
              Value: 03445704
          Numbering:
            – Type: volume
              Value: 80
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cancer Chemotherapy & Pharmacology
              Type: main
ResultId 1